Other non-financial assets |
12. Other non-financial assets | (a) | Below is presented the movement: |
| | | | | | | | | | | | | | | | | As of | | Additions | | | | As of | | Additions | | | | As of | | | January 1, | | and | | | | December 31, | | and | | | | December 31, | | | 2023 | | others | | Disposals | | 2023 | | others | | Disposals | | 2024 | | | US$(000) | | US$(000) | | US$(000) | | US$(000) | | US$(000) | | US$(000) | | US$(000) | | | | | | | | | | | | | | | | Cost: | | | | | | | | | | | | | | | Patents and industrial property (b) | | 15,216 | | 72 | | — | | 15,288 | | — | | — | | 15,288 | Rights-of-use (c) | | 13,720 | | 3,732 | | (475) | | 16,977 | | — | | (4,081) | | 12,896 | Software licenses | | 10,937 | | — | | — | | 10,937 | | 6,102 | | (6,005) | | 11,034 | Goodwill (d) | | — | | 34,023 | | — | | 34,023 | | — | | — | | 34,023 | | | | | | | | | | | | | | | | | | 39,873 | | 37,827 | | (475) | | 77,225 | | 6,102 | | (10,086) | | 73,241 | Accumulated amortization: | | | | | | | | | | | | | | | Rights-of-use (c) | | 9,588 | | 980 | | (274) | | 10,294 | | — | | (131) | | 10,163 | Software licenses | | 6,440 | | 672 | | — | | 7,112 | | 1,129 | | (3,998) | | 4,243 | | | | | | | | | | | | | | | | | | 16,028 | | 1,652 | | (274) | | 17,406 | | 1,129 | | (4,129) | | 14,406 | | | | | | | | | | | | | | | | Cost, net | | 23,845 | | | | | | 59,819 | | | | | | 58,835 |
See related accounting policies in Note 2.4(w). | (b) | The copper plant project is a technological initiative of the Company to develop a viable technical and economic solution for the treatment of complex copper concentrates. This project comprises several stages of development from a laboratory level pilot to a demonstration stage. |
| (c) | Corresponds to the mineral servitude agreements signed with the communities surrounding the Group’s operations, through which the Group is authorized to carry out exploration, development, exploitation and general work activities. |
(d) Corresponds to the higher value paid during the acquisition of the subsidiary El Brocal for US$34,023,000 million from previous years. The Group conducted an impairment test, based on VIU, in order to assess the recoverable amount of El Brocal, consistent with those assumptions and methods described in Notes 2.4(m) and 11(b). No impairment loss was recognized in respect to such goodwill for the years ended as of December 31, 2024 and 2023.
|
Other non-financial assets |
6. Other non-financial assets This item is made up as follows: | | | | | | | December 31, 2024 | | December 31, 2023 | | | US$(000) | | US$(000) | | | | | | Current | | | | | Value added tax (VAT) credit | | 28,853 | | 39,143 | | | | | | Non-current | | | | | Other receivables (a) | | 275,257 | | 274,029 | Uncertain tax positions (b) | | 21,481 | | 18,252 | Other taxes to be recovered | | 1,947 | | 1,981 | | | 298,685 | | 294,262 | | | | | | Total other non-financial assets | | 327,538 | | 333,405 |
| (a) | As of December 31, 2024, represents disbursements made to SUNAT (National Superintendency of Customs and Tax Administration) under protest by the Company through year 2016 of US$181.9 million (US$ 192.6 million as of December 31, 2023), for the years 2015 through 2017 related to customs taxes of US$ 15.9 million (US$16.2 million as of December 31, 2023) and for the year 2018 and 2021 related to social contributions to EsSalud (Social Health Insurance) of US$21.4 million (US$8.4 million as of December 31, 2023 for the year 2018). |
Additionally includes tax credits associated with completion of SUNAT audits through year 2016 of US$56.1 million as of December 31, 2024 (US$56.8 million as of December 31, 2023). According to current tax procedures and the timeframe for resolving these types of claims, management and its legal advisors expect resolution of this matter will be favorable to the Company and amounts will be recoverable (see Notes 13(c) and 13(e)). | (b) | The balance as of December 31, 2024, represents income tax benefits for the years 2017, 2019, 2020, 2022, 2023 and 2024 of US$21.5 million determined in accordance with the International Financial Reporting Interpretations Committee (IFRIC) 23, “Uncertainty over Income Tax Treatments” (US$18.3 million as of December 31, 2023 for the years 2017, 2019, 2020, 2022 and 2023). |
|